ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,20%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,1289
-0,02%
Bitcoin
66.253,21
1,55%
Brent Oil
83,34
0,16%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aquinox Pharmaceuticals Inc (AQXP)

  7. Aquinox Pharmaceuticals Inc (AQXP) Notícias

AQXP

Aquinox Pharmaceuticals (AQXP)

Aquinox Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AQXP
DataHoraFonteTítuloCódigoCompanhia
13/11/201911:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
13/11/201911:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AQXPAquinox Pharmaceuticals Inc
15/10/201918:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AQXPAquinox Pharmaceuticals Inc
11/10/201909:35Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
02/10/201909:39Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
02/10/201909:36Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
20/09/201909:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
13/09/201920:19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
23/08/201916:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
13/08/201918:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/08/201909:00GlobeNewswire Inc.Neoleukin Therapeutics to Present at Canaccord Genuity 39th Annual Growth ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
06/08/201908:00GlobeNewswire Inc.Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreementNASDAQ:AQXPAquinox Pharmaceuticals Inc
15/04/201917:34Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/03/201911:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AQXPAquinox Pharmaceuticals Inc
14/02/201917:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AQXPAquinox Pharmaceuticals Inc
07/11/201812:15GlobeNewswire Inc.Aquinox Pharmaceuticals Announces Third Quarter 2018 Financial ResultsNASDAQ:AQXPAquinox Pharmaceuticals Inc
31/08/201815:22Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:AQXPAquinox Pharmaceuticals Inc
08/08/201807:15GlobeNewswire Inc.Aquinox Pharmaceuticals Announces Second Quarter 2018 Financial ResultsNASDAQ:AQXPAquinox Pharmaceuticals Inc
16/07/201817:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AQXPAquinox Pharmaceuticals Inc
27/06/201807:30GlobeNewswire Inc.Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain SyndromeNASDAQ:AQXPAquinox Pharmaceuticals Inc
11/06/201810:05GlobeNewswire Inc.Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/...NASDAQ:AQXPAquinox Pharmaceuticals Inc
16/05/201814:32GlobeNewswire Inc.Aquinox to Present at 2018 UBS Global Healthcare ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
09/05/201822:00GlobeNewswire Inc.Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including JapanNASDAQ:AQXPAquinox Pharmaceuticals Inc
08/05/201810:05GlobeNewswire Inc.Aquinox Pharmaceuticals Announces First Quarter 2018 Financial ResultsNASDAQ:AQXPAquinox Pharmaceuticals Inc
02/05/201813:54GlobeNewswire Inc.Aquinox to Present at Deutsche Bank 43rd Annual Healthcare ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
26/04/201810:05GlobeNewswire Inc.Aquinox to Present at 2018 Bloom Burton & Co. Healthcare ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
09/04/201807:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AQXPAquinox Pharmaceuticals Inc
21/03/201810:00GlobeNewswire Inc.Aquinox to Present at the 17th Annual Needham Healthcare ConferenceNASDAQ:AQXPAquinox Pharmaceuticals Inc
12/03/201817:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AQXPAquinox Pharmaceuticals Inc
12/03/201817:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AQXPAquinox Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AQXP

Seu Histórico Recente

NYSE
GIX.U
GigCapital2
AMEX
BSJO
Invesco BulletShares 202...
LBNK
NEOMUSDT
NEOM
NASDAQ
ASPS
Altisource Portfolio Sol...
LSE
91VW
Lean Hogs Micro
USOTC
PREKF
Prairiesky Royalty (PK)
EU
C516S
C516S
TSXV
BEL
Belvedere Resources Ltd.
TSXV
TORO
Pucara Gold
KUCN
PLTUSDT
ADD
COIN
MTNSETH
LSE
ZZ33
Citi Fun 24
COIN
SYNBTC
Synapse
BIT
UC6JY4
Unicredit Bank
EU
BEB157669065
Euronext VPU Public auct...
EU
EDFBC
Electricite de France SA...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados